In the US, Rifabutin (rifabutin systemic) is a member of the drug class rifamycin derivatives and is used to treat Mycobacterium avium-intracellulare - Prophylaxis, Mycobacterium avium-intracellulare - Treatment, Tuberculosis - HIV Positive and Tuberculosis - Prophylaxis.
US matches:
- Rifabutin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J04AB04
CAS registry number (Chemical Abstracts Service)
0072559-06-9
Chemical Formula
C46-H62-N4-O11
Molecular Weight
847
Therapeutic Categories
Antibacterial
Antitubercular agent
Chemical Name
(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-6,16,18,20-Tetrahydroxy-1'-isobutyl-14-methoxy-7,9,15,17,19,21,25-heptamethylspiro[9,4-(epoxypentadeca[1,11,13]trienoimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26-(3H,9H)-trione 1 (WHO)
Foreign Names
- Rifabutinum (Latin)
- Rifabutin (German)
- Rifabutine (French)
- Rifabutina (Spanish)
Generic Names
- Rifabutin (OS: BAN, USAN)
- Rifabutina (OS: DCIT)
- Rifabutine (OS: DCF)
- Ansamicin (IS)
- Ansamycin (IS)
- LM 427 (IS: FarmitaliaCarl)
- Rifabutin (PH: BP 2010, USP 32, Ph. Eur. 6)
- Rifabutine (PH: Ph. Eur. 6)
- Rifabutinum (PH: Ph. Eur. 6)
Brand Names
- Ansatipin
Kenfarma, Spain; Pfizer, Finland; Pfizer, Sweden - Ansatipine
SERB, France - Mycobutin
Pfizer, Austria; Pfizer, Australia; Pfizer, Belgium; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, United Kingdom; Pfizer, Hong Kong; Pfizer, Israel; Pfizer, Italy; Pfizer, Netherlands; Pfizer, New Zealand; Pfizer, Portugal; Pfizer, Turkey; Pfizer, Taiwan; Pfizer, United States; Pfizer, South Africa; Pharmacia, Luxembourg; Pharmacia, Romania - Rifabutin Pfizer
Pfizer, Denmark
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment